Bristol-Myers Squibb Company (BMY) Insider Trading
- $16,028,814.61
- $516,752,485.91
- Dec. 5, 2023
- Lamberto Andreotti
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 14, 2016 | SVP | 11,820 | $72.69 | Sell | $859,195.80 | |
| May 20, 2016 | CFO | 30,201 | $70.79 | Sell | $2,137,928.79 | |
| May 16, 2016 | SVP | 3,519 | $72.47 | Sell | $255,021.93 | |
| May 6, 2016 | EVP | 72,544 | $70.39 | Sell | $5,106,372.16 | |
| May 5, 2016 | Director | 23,200 | $70.54 | Sell | $1,636,528.00 | |
| May 3, 2016 | CEO | 34,594 | $71.31 | Sell | $2,466,898.14 | |
| May 2, 2016 | Director | 234,720 | $71.88 | Sell | $16,871,673.60 | |
| May 2, 2016 | SVP | 37,258 | $71.93 | Sell | $2,679,967.94 | |
| May 2, 2016 | Insider | 22,218 | $71.95 | Sell | $1,598,585.10 | |
| April 5, 2016 | Director | 23,200 | $65.90 | Sell | $1,528,880.00 | |
| April 4, 2016 | Director | 15,967 | $101.84 | Sell | $1,626,079.28 | |
| April 4, 2016 | Director | 11,600 | $65.79 | Sell | $763,164.00 | |
| March 9, 2016 | Director | 23,200 | $65.71 | Sell | $1,524,472.00 | |
| March 8, 2016 | Director | 2,500 | $66.00 | Sell | $165,000.00 | |
| March 4, 2016 | SVP | 12,962 | $64.64 | Sell | $837,863.68 | |
| March 3, 2016 | Director | 2,000 | $103.01 | Buy | $206,020.00 | |
| Feb. 22, 2016 | Director | 2,100 | $104.12 | Sell | $218,652.00 | |
| Feb. 17, 2016 | CEO | 12,040 | $63.58 | Sell | $765,503.20 | |
| Feb. 17, 2016 | EVP | 10,152 | $63.57 | Sell | $645,362.64 | |
| Feb. 12, 2016 | Director | 23,200 | $59.61 | Sell | $1,382,952.00 | |
| Jan. 5, 2016 | Director | 23,200 | $67.56 | Sell | $1,567,392.00 | |
| Jan. 4, 2016 | Director | 11,600 | $66.93 | Sell | $776,388.00 | |
| Dec. 28, 2015 | Director | 40,000 | $119.36 | Sell | $4,774,400.00 | |
| Dec. 23, 2015 | Director | 20,000 | $122.11 | Sell | $2,442,200.00 | |
| Dec. 21, 2015 | Director | 14,464 | $110.62 | Sell | $1,600,007.68 | |
| Dec. 15, 2015 | Director | 23,200 | $69.03 | Sell | $1,601,496.00 | |
| Nov. 20, 2015 | Director | 23,200 | $67.39 | Sell | $1,563,448.00 | |
| Oct. 6, 2015 | Director | 23,200 | $60.86 | Sell | $1,411,952.00 | |
| Sept. 10, 2015 | Director | 15,000 | $122.45 | Sell | $1,836,750.00 | |
| Sept. 8, 2015 | Director | 15,000 | $121.76 | Sell | $1,826,400.00 | |
| Sept. 3, 2015 | Director | 23,200 | $59.40 | Sell | $1,378,080.00 | |
| July 13, 2015 | Insider | 30,156 | $120.78 | Sell | $3,642,241.68 | |
| June 10, 2015 | Director | 15,000 | $111.74 | Sell | $1,676,100.00 | |
| June 9, 2015 | Director | 15,000 | $111.18 | Sell | $1,667,700.00 | |
| June 4, 2015 | SVP | 16,972 | $65.71 | Sell | $1,115,230.12 | |
| March 16, 2015 | Insider | 12,000 | $66.96 | Sell | $803,520.00 | |
| March 16, 2015 | EVP | 114,666 | $67.81 | Sell | $7,775,501.46 | |
| Feb. 26, 2015 | Director | 15,000 | $122.89 | Sell | $1,843,350.00 | |
| Feb. 17, 2015 | General Counsel | 11,746 | $60.39 | Sell | $709,340.94 | |
| Feb. 12, 2015 | SVP | 3,880 | $59.26 | Sell | $229,928.80 | |
| Feb. 6, 2015 | Insider | 117,099 | $120.68 | Sell | $14,131,507.32 | |
| Feb. 6, 2015 | SVP | 21,478 | $60.15 | Sell | $1,291,901.70 | |
| Jan. 29, 2015 | CEO | 90,246 | $61.14 | Sell | $5,517,640.44 | |
| Jan. 29, 2015 | Insider | 5,250 | $60.73 | Sell | $318,832.50 | |
| Jan. 29, 2015 | Director | 2,500 | $60.89 | Sell | $152,225.00 | |
| Jan. 15, 2015 | Insider | 26,666 | $120.01 | Sell | $3,200,186.66 | |
| Jan. 2, 2015 | Director | 45,536 | $113.47 | Sell | $5,166,969.92 | |
| Dec. 8, 2014 | Director | 15,000 | $118.20 | Sell | $1,773,000.00 | |
| Dec. 5, 2014 | CEO | 75,000 | $60.31 | Sell | $4,523,250.00 | |
| Nov. 3, 2014 | Insider | 158,000 | $106.68 | Sell | $16,855,440.00 |
Insiders are both buying and selling Bristol-Myers Squibb Company stock.
The insider traders at Bristol-Myers Squibb Company are: Lamberto Andreotti, Giovanni Caforio, Gilla Kaplan, James M Cornelius, Ernest Mario, Sandra Leung, Rupert Vessey, Joseph C Caldarella, James J Loughlin, Michael D Casey, Louis S Schmukler, Autenried Paul Von, Theodore R Samuels II, John E Elicker, Robert J Hugin, Ann Powell, Samuel J Moed, Adam Dubow, Beatrice J Cazala, Charles A Bancroft, Christopher S Boerner, Mark J Alles, Michael A Friedman, Joseph Caldarella, James Cornelius, Joseph Eid, Karen Murphy Santiago, Francis M Cuss, Lewis B Campbell, Louis Schmukler, Thomas O Daniel, Michael D. Casey, Perry A Karsen, Richard W Barker, Dinesh C Paliwal, David V Elkins, Terrie Curran, Elliot Sigal, Charles Bancroft, Michael W Bonney, John H Weiland, Perry Karsen, Carrie Smith Cox, Robert J Bertolini, Thomas Daniel, Lawrence Stein, Lawrence V Stein, Robert M Plenge, Lewis Campbell, John Elicker, Francis Cuss, Thomas J Jr. Lynch, Corp /De/ Celgene, and Michael Casey
The most active insider trader at Bristol-Myers Squibb Company is Lamberto Andreotti with 27 trades.
Robert J Hugin has sold the most Bristol-Myers Squibb Company stock with a total value of $90,990,863.06.
Corp /De/ Celgene has bought the most Bristol-Myers Squibb Company stock with a total value of $22,404,200.00.
The most recent insider trade for Bristol-Myers Squibb Company was on Dec. 5, 2023.
The single biggest insider buy for Bristol-Myers Squibb Company was from Corp /De/ Celgene with a total value of $11,202,100.00 on Oct. 24, 2016.
The single biggest insider sell for Bristol-Myers Squibb Company was from Robert J Hugin with a total value of $23,604,615.80 on June 22, 2017.